BLOOMFIELD HILLS, Mich.--(BUSINESS WIRE)--Zivo Bioscience, Inc. (NASDAQ: ZIVO) (the “Company”), a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional ...
BLOOMFIELD HILLS, Mich., August 23, 2024--(BUSINESS WIRE)--ZIVO Bioscience, Inc. (OTCQB: ZIVO), a pioneering biotech/agtech R&D company dedicated to developing therapeutic, medicinal and nutritional ...
BLOOMFIELD HILLS, Mich.--(BUSINESS WIRE)--Zivo Bioscience, Inc. (NASDAQ: ZIVO) (the “Company”), a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional ...
A reduction in viral titers (viral shedding) in infected birds receiving ZIVO’s products compared with untreated infected controls. A delay in transmission of LPAI when healthy birds were exposed to ...
ZIVO Bioscience, Inc. (OTCQB:ZIVO) is a research and development (R&D) company operating in the biotech as well as the agritech sectors, with an intellectual property (IP) portfolio comprising ...
The average one-year price target for Zivo Bioscience (NASDAQ:ZIVO) has been revised to 36.72 / share. This is an increase of 500.00% from the prior estimate of 6.12 dated October 4, 2023. The price ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback